CapsCanada® provides integrated services for LFHC development and manufacturing from product development concept through clinical trials, manufacturing and commercialization.
Our technology and manufacturing service enables to fill liquids, suspensions, semi-solids, pastes and waxy substances into gelatin or Hypromellose (HPMC) two-piece capsules.
LFHCs are an appealing dosage form that can overcome complex formulation challenges.
Scaleup from demonstration batches and clinical batches is linear, meaning faster product launches. LFHCs also provide faster therapeutic relief than competing technologies, as well as higher stability
We bring that same commitment to developing long-term partnerships with our customers. Contact us today to put decades of capsule expertise to work for you.